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Supplementary Issue: Gene and Protein Expression Profiling in Disease

Abstract: Biomarker identification is often associated with the diagnosis and evaluation of various diseases. Recently, the role of microRNA (miRNA)
has been implicated in the development of diseases, particularly cancer. With the advent of next-generation sequencing, the amount of data on miRNA
has increased tremendously in the last decade, requiring new bioinformatics approaches for processing and storing new information. New strategies have
been developed in mining these sequencing datasets to allow better understanding toward the actions of miRNAs. As a result, many databases have also
been established to disseminate these findings. This review focuses on several curated databases of miRNAs and their targets from both predicted and
validated sources.
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Introduction

In 1956, Crick stated the central dogma of molecular bio
logy describing the f low of information from DNA to
RNA to protein.1 Although the process of information
transmission was oversimplified, the central dogma hinted
at the wealth of information that can be extracted from
every biological sequence. The mining of information from
nucleotide and protein sequences prompted the develop
ment of bioinformatics, the science that interfaces biology
and computer science to answer biological questions on a
molecular level. Sequence-based discovery allows the elu
cidation of the relationships between structure, function,
and evolution. Discovering the relationships between our
genetic sequences and the various genetic actions, includ
ing the causes of diseases, is one of the main goals of
bioinformatics.
The development of biomarker identifications is often
associated with the diagnosis and evaluation of various dis
eases. Many biomarkers are macromolecules of nucleic acids,
carbohydrates, and proteins in nature. The initial isolation of
nucleic acid-based biomarkers requires the need for genomics
as opposed to proteomics, which is needed to isolate proteinbased biomarkers. These raw -omic outputs are often subjected
to further analyses with bioinformatics techniques that focus
on particular aspects of the dataset, specifically, in this dis
cussion, biomarkers.2 Recently, there has been an increased
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emphasis on the role of microRNA (miRNA) as a biomarker
in the diagnosis and possible treatment for cancer.3,4 miRNAs
are small single-stranded noncoding RNAs that control gene
expression at the posttranscriptional level. miRNAs act as
posttranscription regulators of mRNA by binding to a specific
miRNA-binding site on the 3′-untranslated region (3′-UTR)
of mRNA.5 They are often regarded as both predictive and
prognostic biomarkers.6 Sequence-level polymorphisms in
miRNA or their target sites can have strong downstream
effects in phenotype. These polymorphisms have been impli
cated in a number of diseases, ranging from cancer, diabetes,
Parkinson’s, and Alzheimer’s. For example, miRNAs have
been considered as a serum biomarker for cancer diagnosis
and prognosis, particularly in B-cell lymphoma as noted by
Lawrie et al.7
With the advent of next-generation sequencing (NGS),
the identification and quantitation of miRNA as bio
markers are becoming more precise. Many experiments of
miRNA quantitation were the results of whole transcriptome
sequencing, often referred to as RNA-seq.8 The hallmark
feature of NGS is the ability to elucidate millions of strands
of nucleotides simultaneously, which results in an unprece
dented amount of coverage for any genome. While NGS is of
great interest to many readers, the technical detail is beyond
the scope and the allotted space of this review. For users
interested in NGS technology, review articles by Mardis,
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Mutz et al, and Koboldt et al provide a thorough coverage on
its usage and application.9–12 For readers interested in NGS
and classical methods of miRNA discovery, Eminaga et al,
Tam et al, and Git et al provide an excellent overview for
the processes.13–15
NGS is also known as massive parallel sequencing or
deep sequencing due to its potential outputs. Consequently,
the amount of data generated has also been unprecedented.
This requires the establishment of corresponding protocols
in processing miRNA data from RNA-seq experiments. For
bioinformatics to contribute to the analysis of these RNAseq datasets, protocols need to be created for finding the
most relevant miRNA species. While the main goal of this
review is to focus on various repositories of miRNAs and
their interactions, it is worthy of note that efforts of compu
tational approaches, such as miRClassify,16 are also accele
rating the overall annotation process of miRNAs. In addition,
TargetScan,17 miRanda,18 and PicTar19 are the leading pro
grams in the field, as reflected by the number of citations.
For other computational approaches, it is recommended that
readers should review articles by Zou et al, Wang et al, and
Wei et al.16,20,21
As one of the most important goals in bioinfor
matics, the proper storage and organization of data will
lead to easy retrieval and dissemination of information.
This review focuses on the specific aspect of databases in
miRNA discovery. S everal databases are discussed below.
The inclusion of databases reviewed here must meet the
following criteria: (1) clear documentation of updates and
history, (2) recent updates in the past 12 months, and (3)
not a simple derivative on data from another database. The
major features of each database reviewed here are summa
rized in Table 1.

miRBase

miRBase (www.mirbase.org) combines the knowledge of
miRNA and NGS to create a repository aimed at assigning
stable and consistent names to novel miRNAs. 22 While it can
be accessed via its web interface, bulk download via file trans
fer protocol is also available. Established in 2002, miRBase
was originally called the miRNA Registry, which allowed
submissions of novel miRNAs to be named in a consistent and
organized fashion.23 Its first release contained 218 miRNA
loci from five species. As of June 2014, after continuous
growth, release 21 contains 28,645 entries representing hair
pin precursor miRNAs that expressed 35,828 mature miRNA
products in 223 species. miRBase can be used for searching
and browsing both hairpin and mature sequences.
Since the inception of miRBase, the annotation strat
egy was developed and continually improved to organize all
the information associated with miRNA species. Its goal was
to officialize identifiers as quickly as possible for publication
in articles. For example, the prefix in dme-mir-100 desig
nates the organism and is followed by sequentially assigned
numbers. Recently, for sequences derived from the 5′ and 3′
arms of the hairpin precursor, names are assigned as dmemiR-100-5p and dme-miR-100-3p, respectively, to specify
the mature sequences. This standardized scheme also includes
a strategy where homologous miRNA loci are assigned the
same number from different species. Two of the most recent
developments for miRBase are associated with the advances of
NGS technology and community-based contributions toward
the textual and functional information on miRNAs. 22 The
curators for miRBase attributed the most recent database addi
tions to the next-generation or deep sequencing. This has led
to more research groups participating in the process. Similar
to many other knowledge bases, the annotation process is also

Table 1. Summarized features from databases reviewed.
Database

Main Feature

Annotation

Download
Options

Integrated Tools,
API and Visualization

Data Source

mirBase

Nomenclature assignment

Manual, automated
(text mining)

EMBL, fasta,
gff3

Stem-loop, deepsequencing

SRA, GEO, PubMed,
community

miRDB

Functional annotation

Automated
(machine-learning)

Spreadsheet,
flat file

n/a

PubMed, RNA-seq,
miRBase

mirWalk

Predicted binding sites

Mutomated
(multiple programs)

Search tables

n/a

Refseq 61, miRBase

mirTarBase

miRNA-target interactions

Manual, automated
(NLP)

Spreadsheet,
flat file

Word cloud, expression
profile, structure of premiRNA, CytoscapeWeb

TCGA, GEO, CLIP-seq,
CLASH-seq,
Degradome-seq

mirCancer

miRNA expression

Manual, automated
(text mining)

Flat file

n/a

miRBase, PubMed

doRiNA

RNA binding proteins
(RBPs), miRNA

Automated pipeline

BED file

UCSC Genome Browser,
REST, Python API

GEO, CLIP-seq,
selected literature

SomamiR

Somatic and germline
mutations

Automated, aided by
KEGG

Spreadsheet

n/a

NHGRI GWAS, TCGA

EDRN

Biomarker information

Manual, automated
in EDRN Catalog and
Archive Service (eCAS)

Flat file

Biomarker Summary
Information, BioMuta

Studies from participants
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c ommunity based in miRBase. Two major sources are involved
in the annotation process: publications from PubMed and
contribution of textual and functional annotations from the
miRNA community. miRBase provides primary references for
each miRNA sequence describing its discovery, links to evi
dence supporting the annotation, coordinates on the genome,
and links to databases of predicted and validated target sites.
miRBase can be searched with identifiers or keywords along
with genomic location. miRNA sequences were also collected
and mapped from the Gene Expression Omnibus (GEO) and
the Short Read Archive, which are hosted by the National
Center for Biotechnology Information (NCBI).

miRDB

While serving as an online resource for functional annota
tions, miRDB (www.mirdb.org) also functions as a reposi
tory for miRNA-target predictions with data downloaded
from version 21 of miRBase.24 Users can also submit their
own sequences for prediction at miRDB. As of early 2015,
2.1 million predicted gene targets regulated by 6,709 miRNAs
are included in miRDB. The above target prediction was per
formed with MirTarget.24 MirTarget was developed by ana
lyzing high-throughput expression profiling data in a support
vector machine framework. The MirTarget algorithm also
serves as the back-end for the web server interface in predic
tion. One of the most recent developments was the inclusion
of integrated computational analyses with literature, result
ing in a new strategy and a scoring system for the identifi
cation of functional miRNA with the following four selection
criteria. First, PubMed literature mining was utilized to map
NCBI gene database for the association of miRNAs with cor
responding PubMed records. Second, sequence conservation
among different species was considered as functionally impor
tant. Third, expression profiles from 81 RNA-seq experiments
were used for functional miRNA identification. Fourth, func
tional annotations by miRBase resulted in the identification
of high confidence human miRNAs with structural analysis and
expression counts. Furthermore, to alleviate falsely identified
miRNAs from high-throughput sequencing, the curators of
miRDB used a combination of computational analyses and
literature mining to identify 568 and 452 functional miRNAs
in humans and mice, respectively, for the FuncMir collection
in miRDB (http://mirdb.org/miRDB/FuncMir.html).

miRWalk

The third database reviewed is miRWalk (mirwalk.uni-hd.de),
which hosts predicted and validated miRNA-binding sites
along with information on all known genes of human,
mouse, and rat.25 Similar to miRDB, miRWalk also uti
lizes automated text mining searches of PubMed to extract
information on miRNAs. It is designed as a comprehensive
database for predicted and validated targets for miRNAs asso
ciated with genes, pathways, diseases, organs, cell lines, and
transcription factors.

One of the goals for miRWalk is to use a computa
tional approach to identify the longest consecutive comple
mentary regions between miRNA and gene sequences. The
identified miRNA binding sites are generated with the
miRWalk algorithm and then combined with the results of
many other established prediction programs and databases,
including DIANA-microTv4.0, 26,27 DIANA-microT-CDS, 26
miRanda-rel2010,18 mirBridge, 28 miRDB4.0, 24 miRmap, 29
miRNAMap, 30
doRiNA, 31
PicTar2,19
RNA22v2, 32
RNAhybrid2.1, 33 and TargetScan6.2.34 Continual updates
and upgrades are the goals for improving miRWalk. Recently,
the comparative platform of miRNA-binding sites within the
mRNA 3′-UTR region was also upgraded with 13 miRNAtarget prediction datasets. All results described above can be
found via the web interface of miRWalk 2.0, containing two
modules: predicted target module (PTM) and validated tar
get module (VTM). The PTM provides novel comparative
platforms of binding sites for the promoter, coding sequence
(CDS), and 5′- and 3′-UTR regions. The VTM contains inter
action information associated with genes, pathways, organs,
diseases, cell lines, Online Mendelian Inheritance in Man
(OMIM) disorders, and literature on miRNAs, in addition
to information on proteins known to be involved in miRNA
processing. The above modules are categorized into differ
ent search pages to allow users to retrieve miRNA-associated
information using different identifiers.

miRTarBase

The miRTarBase (mirtarbase.mbc.nctu.edu.tw) aimed to
provide “the most current and comprehensive informa
tion of experimentally validated miRNA-target interactions
(MTIs).”35 For its initial launch of version 1.0 in 2010, the data
base utilized over 100 published studies. As of September 15,
2015, version 6.0 is the most current iteration of miRTarBase
containing 4,966 articles and 3,786 miRNAs. In compa
rison to databases that provide collections of miRNAs without
deeper annotation, the uniqueness of miRTarBase is the cura
tion on MTIs with both manual and computer-aided methods
together with a robust suite of tools for the visualization of
MTIs and diseases.
In the most recent release, over 360,000 MTIs were col
lected by manual review after applying natural language pro
cessing (NLP) on literature text. In comparison to others, the
application of an artificial intelligence approach by the curators
of miRTarBase, such as NLP, is a unique feature and should
increase the number of relevant articles in the database. Unlike
other miRNA databases, miRTarBase contains many robust
features of graphical visualization. For instance, the word cloud
is a new feature to visualize relationships between individual
miRNA and medical conditions. For interactions between
miRNAs and their respective targets, Cytoscape Web can be
integrated to aid the understanding of miRNA-target regula
tion.36 Beyond the usage of Cytoscape Web, the curators also
used the Database for Annotation, Visualization and Integrated
Biomarker Insights 2015:10(S4)
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Discovery (DAVID) gene annotation tool to perform gene
ontology and Kyoto Encyclopedia of Genes and Genome
(KEGG) pathway enrichment annotation to further examine
the functions of the target genes involved in MTIs.37–39 These
MTIs and associated annotations can be searched by users via
the interfaces of the species browser and search utility. The
above two interfaces have recently undergone enhancement
and redesign. This allows basic MTI searches by miRNA, tar
get gene symbol, validation method, or PubMed ID.
Other than user interface and visualization tools, miR
TarBase sets itself apart from similar databases by incorporat
ing datasets from NCBI GEO (www.ncbi.nlm.nih.gov/geo/)
and The Cancer Genome Atlas (TCGA) (cancergenome.
nih.gov/) to provide miRNA-target gene expression profiles.
Specifically, TCGA provides clinical aspects of miRNA and
gene expression profiles. Gene expression profiles from the
above two data sources are currently considered as a method
for experimental validation with the NGS technology. Several
specific approaches involving NGS technology are currently
being utilized by the curators, including cross-linking and
immunoprecipitation (CLIP)-seq,40 crosslinking, ligation,
and sequencing of hybrids (CLASH-seq),41 and degradomeseq.42 Overall, miRTarBase contains 21 human CLIP-seq
datasets, 5 mouse CLIP-seq datasets, 6 nematode datasets,
and 1 human CLASH-seq dataset.
For readers specifically interested in miRNA and cancer, miR
Cancer (mircancer.ecu.edu) provides a comprehensive collection
on the expression of miRNAs via text mining of PubMed.43 The
components for this approach are literature collection, named
entity and expression recognition, rule matching, voting, man
ual verification, and recording. Regular expressions were first
used to identify miRNA in literature for miRCancer with miR
and miR- for locating miRNA names. Species prefixes, such as
hsa- and mmu-, were also used as a part of the regular expres
sions in searching for related literature. For recognition of can
cer names, a cancer name dictionary was compiled from the
International Classification of Diseases for Oncology (codes.
iarc.fr). The curators also established a dictionary for miRNA
expression with 28 terms to include common keywords and
phrases for upregulation and downregulation. The text mining
approach for miRCancer further relies on 75 rules constructed
by the curators using sentence structures commonly found in
describing miRNA expressed in cancer cells. These rules are
hard-coded sentence structures. Manual revision is then car
ried out to improve automated extraction. As of March 2015,
44,353 miRNAs for 173 cases of human cancer are associated
with 2,073 publications in miRCancer.

It is a database of RNA interactions in posttranscriptional
regulation, with predictions carried out by PicTar.19 Unlike
other miRNA databases, doRiNA 2.0 (dorina.mdc-berlin.de)
stands out with a strong capability for local implementation,
allowing integration into third-party pipelines. Further
more, doRiNA 2.0 solicits user feedback, can be implemented
locally, and operates on an open-source model. As a part of the
upgraded version 2.0, the developers also reworked the user
interface and expanded the database to improve the usability
of the website. It therefore should be considered as one of the
most unique and technically sophisticated databases.
Developers of doRiNA 2.0 collected and integrated
all available data on miRNA and RBP target sites from the
public domain. More than 67 new publicly available RBP
datasets have been added into doRiNA 2.0. In the latest ver
sion of doRiNA, miRNA and their targets were identified
with both computational predictions and new experimental
techniques by chimeric sequencing reads. Due to the lack of
reliable in silico predictions of RBP target sites, the curators
have decided to focus on high-resolution, transcriptome-wide
CLIP experiments. All candidate miRNA target sites are still
subject to probabilistic scoring by a hidden Markov model.
Data from various cell lines of human, mouse, roundworm,
and fly are available in Browser Extensible Data (BED) for
mats, allowing integration of coordinates and annotation
tracks with the UCSC Genome Browser.45
Recent updates in version 2.0 provide various improve
ments from the previous version. Developers of doRiNA paid
special attention toward the infrastructure and interoperabil
ity surrounding their repository. doRiNA 2.0 can now achieve
high query speed and complexity by precomputing several
important data characteristics. External developers can eas
ily integrate doRiNA 2.0 into third-party analysis piplines via
a representational state transfer application program interface
(API), while the Python API can be used for local queries by
users. Documentations for the above two APIs can be found
at http://dorina.mdc-berlin.de/docs. The developers have also
migrated away from the traditional Common Gateway Inter
face (CGI) and Structured Query Language (MySQL) imple
mentations and instead used a fast key-value cache and store
(redis.io) as well as in-memory caching of frequent queries for
faster access. Mirrored sites and database servers are utilized
by doRiNA 2.0 to achieve high service availability. Both the
web application and the APIs are available under an opensource license approved by the Open Source Interconnection
that permits research and commercial access and reuse. The
developers at doRiNA essentially created an ecosystem that pro
vides a user-friendly environment while encouraging external
developers to adapt this miRNA repository.

doRiNA 2.0

SomamiR

miRCancer

The main goal of doRiNA is to create a single framework for the
systematic curation, storage, and integration of RNA-binding
proteins (RBPs) and miRNAs from different species.31,44
56
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SomamiR (compbio.uthsc.edu/SomamiR/) was created to
integrate heterogeneous datasets to investigate the impact
of somatic and germline mutations on miRNA function in
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c ancer.46 It specifically contains experimentally determined
germline and somatic miRNA mutations associated with
cancer, along with their target sites. A total of 15 sources of
somatic mutations that have been identified from wholegenome sequencing of paired normal and cancer samples were
analyzed and incorporated into SomamiR.
Three methods were used to predict how mutations may
impact target sites in SomamiR. First, a comprehensive list
of how somatic mutations may alter miRNA-binding sites
was created with methods established by Ellwanger et al.47
Second, two popular miRNA-target prediction algorithms,
TargetScan17 and PITA,48 were used to determine mutations
that are more likely to alter functional binding sites. Third, five
major types of information were used to annotate miRNAs,
genes, and target locations in SomamiR: results of association
studies, gene pathways, sequence conservation, expression of
miRNAs in cancer, and germline mutations. For association
studies, high scoring markers from genome-wide associa
tion studies (GWAS) of cancer in National Human Genome
Research Institute (NHGRI) GWAS catalog were collected.
The data on meta-analysis of cancer candidate gene associa
tion studies from the Cancer GAMAdb49 were also collected.
Developers also carried out functional annotation of genes
containing somatic mutations that alter miRNA target sites
with the KEGG. They further highlighted genes with somatic
mutations from miRNA target sites in each pathway. To
improve miRNA-target prediction, the conservation of a target
site sequence across species has been used. A 46-way multiZ50
alignment of vertebrate genomes was utilized to determine
whether the sequence of a predicted target site was conserved.
To better understand somatic cell mutations associated with
cancer, miRNA expression data from various cancer genome
sequencing projects deposited at TCGA were also collected.
In addition to somatic cell mutations, germline mutations that
alter predicted and experimental miRNA target sites were col
lected from PolymiRTS.51 The name PolymiRTS derives from
polymorphisms in miRNAs and their target sites. PolymiRTS
is a database for tracking and identifying sequence polymor
phisms in miRNAs or their target sites to possibly reveal links
to molecular, physiological, and behavioral disease phenotypes.
In SomamiR, each gene is represented by a single web
page to provide all somatic mutations that alter miRNA target
sites in the gene, as well as associate with specific types of can
cer. Each web page representing a gene can also be accessed
through several browsable tables that are linked from the data
base homepage. These browsable tables contain somatic muta
tions in miRNAs and respective target sites. Furthermore,
experimental evidence linking these mutations to various can
cer types is also incorporated into these tables. Two additional
tables can be used to browse database entries in the context of
association studies and KEGG gene pathways. SomamiR also
allows the following criteria for searching against the database:
miRNA, gene symbol, RefSeq ID, and chromosome location.
The search can be performed using the form on the website or

by uploading a batch file with multiple terms. For users who
are interested in parsing the database for further analysis, the
complete content of SomamiR is also available for download
at http://compbio.uthsc.edu/SomamiR/download/.

Early Detection Research Network (EDRN)

While the above-described databases are exclusively for the dis
covery and understanding of miRNAs, other repositories can
contain similar information from various types of biomarkers.
One such effort in categorizing data related to multiple types
of biomarkers is EDRN from the National Cancer Institute52
(edrn.nci.nih.gov). While EDRN is not exclusively desig
nated as a sequence-level repository, biomarker data, includ
ing miRNAs, can be found under the section of informatics.
Several tools are under the informatics section with a link to
Biomarker Database being the most relevant to this review.
The database is further divided into five sections: biomarkers,
studies, publications, terms/glossary, and sites. Some data can
be visualized using BioMuta, a curated single nucleotide vari
ation and disease association database where the variations are
mapped to the genome/protein/gene. Finally, EDRN is also
aiming at establishing biomarker bioinformatics standards
and ontology for the community.

Conclusion

While data repositories were the main focus for this review,
miRNA-target prediction also presents other interesting
questions in bioinformatics. It is more challenging to predict
miRNA targets in animals than in plants, due to imperfect
base pairing with target sites. This demonstrates the potential
limitation for any prediction algorithms due to the complex
ity of many biological systems. There will be a strong need
for further improvements to develop accurate predictions for
miRNA targets. In addition to the goal of predicting miRNA
targets, the selected miRNA databases reviewed above share
the commonality of relying on textual information, mostly
from PubMed, in the retrieval of relevant literature. It is also
important for readers to note that one of the most important
efforts is the standardization of biomarker nomenclature,
including various miRNAs by EDRN. Standardization will
improve the interoperability among different research groups
and databases. Furthermore, nearly all curators for the above
repositories recognized that major growth of data will result
from sequencing. With the advent of new technologies, there
is no doubt that more miRNAs will be discovered, resulting in
an exciting new era for researchers.
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